Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Gains from Sales and Divestitures: 2025

Historic Gains from Sales and Divestitures for Phibro Animal Health (PAHC) over the last 1 years, with Jun 2025 value amounting to $30,000.

  • Phibro Animal Health's Gains from Sales and Divestitures was N/A to $30,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $30,000, marking a year-over-year change of. This contributed to the annual value of $30,000 for FY2025, which is N/A change from last year.
  • Phibro Animal Health's Gains from Sales and Divestitures amounted to $30,000 in FY2025.
  • Phibro Animal Health's 5-year Gains from Sales and Divestitures high stood at $30,000 for FY2025, and its period low was $30,000 during FY2025.
  • Its 1-year average for Gains from Sales and Divestitures is $30,000, with a median of $30,000 in 2025.